These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14107028)

  • 21. Betapropiolactone in sterilization of vaccines, tissue grafts, and plasma.
    HARTMAN FW; LOGRIPPO GA
    J Am Med Assoc; 1957 May; 164(3):258-60. PubMed ID: 13415972
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of combined beta-propiolactone/ultraviolet irradiation treatment on hepatitis B virus.
    Prince AM; Stephan W
    Lancet; 1980 Oct; 2(8200):917. PubMed ID: 6107566
    [No Abstract]   [Full Text] [Related]  

  • 23. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
    Stephan W
    Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus.
    SMOLENS J; STOKES J
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monitoring of sterilization procedures for plasma derivatives using bacteriophages].
    Dichtelmüller H; Stephan W
    Immun Infekt; 1988 Feb; 16(1):18-20. PubMed ID: 3283031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [STUDY OF ANTIBODY RESPONSE TO ANTIMEASLES VACCINE KILLED WITH BETA-PROPIOLACTONE IN THE GUINEA PIG AND IN GROUPS OF INFANTS BETWEEN 1 AND 24 MONTHS OF AGE].
    BRANCATO P; ALBANESE M; GULLO A
    Riv Ist Sieroter Ital; 1964; 39():374-84. PubMed ID: 14187848
    [No Abstract]   [Full Text] [Related]  

  • 29. INFECTIOUS HEPATITIS AND THE ROLE OF CHEMOTHERAPEUTICS IN VIRAL DISEASES TRANSMITTED BY BLOOD TRANSFUSIONS: SERIES III.
    DAWSON D; ZAJTCHUK R; ALLEN JG
    J Surg Res; 1964 Jan; 4():47-8. PubMed ID: 14106393
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis-free reagents in tests for Australia antigen.
    Stephan W
    Vox Sang; 1973; 24():Suppl:78-9. PubMed ID: 4719497
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of beta-propiolactone for the sterilization of heat-labile materials.
    Hazeu W; Hueck HJ
    Antonie Van Leeuwenhoek; 1965; 31(3):295-300. PubMed ID: 4953812
    [No Abstract]   [Full Text] [Related]  

  • 32. The inactivation of rinderpest virus by beta-propiolactone and its effect on homologous complement-fixing and neutralizing antibodies.
    STONE SS; DELAY PD
    J Immunol; 1961 Oct; 87():464-7. PubMed ID: 13917476
    [No Abstract]   [Full Text] [Related]  

  • 33. Destruction of enteric bacteria in liquid egg with beta-propiolactone.
    BRUCH CW; KOESTERER MG
    Appl Microbiol; 1962 Mar; 10(2):123-8. PubMed ID: 13873825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procedure for bone sterilization with beta-propiolactone.
    LOGRIPPO GA; BURGESS B; TEODORO R; FLEMING JL
    J Bone Joint Surg Am; 1957 Dec; 39-A(6):1356-64. PubMed ID: 13481049
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
    Dichtelmüller H; Stephan W; Prince AM; Brotman B
    Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
    [No Abstract]   [Full Text] [Related]  

  • 37. [The reaction of beta-propiolactone with serum proteins and amino acid derivatives (author's transl)].
    Determann H; Joachim HU
    Z Klin Chem Klin Biochem; 1971 Sep; 9(5):398-401. PubMed ID: 5173516
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there an effective acceptable procedure for virus removal? Status of betaprone for cold sterilization of biologic products.
    LoGrippo GA
    Vox Sang; 1969 Jul; 17(1):52-60. PubMed ID: 5819619
    [No Abstract]   [Full Text] [Related]  

  • 39. Graft sterilization; a bacteriological and histological study of the relative merits of ethylene oxide and beta-propiolactone as tissue sterilizing agents, with special reference to arterial grafts.
    SUTHERLAND TW; WILLIAMSON GM; ZINNEMANN K; SHUCKSMITH HS
    Br Med J; 1958 Mar; 1(5073):734-6. PubMed ID: 13510783
    [No Abstract]   [Full Text] [Related]  

  • 40. [THE INFLUENCE OF BETA-PROPIOLACTONE ON BACTERIA AND VIRUSES. 1. INACTIVATION].
    POTEL J; JUNGHANS R
    Arzneimittelforschung; 1964 Nov; 14():1254-7. PubMed ID: 14320706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.